Australia’s biggest medicinal cannabis extraction and contract manufacturing plant will be built at a secret location in Melbourne’s south-east in a $50 million project aiming to help the local industry become more self-sufficient.
The facility will be owned, funded and operated by The Valens Company, a Canadian medicinal cannabis business listed on the Toronto Stock Exchange. However, an Australian distributor of medicinal cannabis, Cannvalate, is managing the project, hiring staff and fitting it out with the necessary equipment.
Dr Sud Agarwal, chief executive of Cannvalate, says the new medicinal cannabis manufacturing plant will reduce Australia’s reliance on imported products.Credit:Simon Schluter
The 4500 square metre facility will process raw material and produce a range of finished medicines, including soft gel capsules, tablets and ointments. It will have double perimeter fences, 24 hour CCTV and a range of other security measures, including a vault where finished products will be stored.
„It will be very, very secure,” said Cannvalate chief executive Sud Agarwal.